Emetant 150 mg Injection is in a class of medicines called antiemetics. It is a prodrug of the NK1 receptor antagonist aprepitant and administered intravenously. Emetant 150 mg Injection can be used along with other antiemetic agents to prevent acute and delayed nausea and vomiting in adults caused by chemotherapy treatments.
It is an effective medication to prevent nausea and vomiting caused by cancer chemotherapy treatments. It can also be used for children older than 6 months of age.
Emetant 150 mg Injection administered intravenously (into a vein) comes as a powder form and is to be mixed with liquid by a health care professional, nurse or doctor in a medical facility. It is given as 1 time on the first day of a cancer chemotherapy treatment cycle. Frequency and dosage of Emetant 150 mg Injection injection is decided by your health care professional or doctor. You should inform your health care, professional or doctor, if you face any serious side effects.
Emetant 150 mg Injection (active form) is a selective NK-1 receptor antagonist that is because it will help to block the action of neurokinin. It will prevent acute and delayed nausea and vomiting in patients experiencing after receiving certain chemotherapy treatments.